RxDoctor Payments Data

Caleb Norton

Cardiovascular Disease · Saint Louis, MONPI 1447782800

Payments from drug & device makers

What this record shows

This record is dominated by grants: $25,090 of the $40,071 with a category attached, or 62.6%. 12 manufacturers reported payments, led by Abbott at 37.9% of the total. Reporting peaked in 2023 at $18,076 and has fallen 69.3% since, to $5,555 in 2025. Among cardiovascular disease clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$40,071in general payments, 2019–2025

Across 198 payments — averaging $202.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$15K
  • Medtronic$13K
  • Boston Scientific$9K
  • Biosense Webster, Inc.$2K
  • Biotronik Inc.$248
  • Cardiovascular Systems Inc.$133
  • plus $269 from 6 others

What the payments were for

  • Grants$25,09063%
  • Travel & lodging$5,36313%
  • Food & beverage$8,90822%
  • Education$6262%
  • Entertainment$840%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,071 in reported general payments places this provider in the 90th percentile of 391 cardiovascular disease providers in Missouri.

See all cardiovascular disease providers in Missouri

Other cardiovascular disease in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →